synthesis by primary cultures of intestinal mononuclear cells isolated from colonic mucosa of five ulcerative colitis patients was enhanced but not significantly different from its synthesis by cells isolated from normal subjects. These results suggest that the enhanced intestinal prostanoid synthesis in active Crohn's disease is derived from stimulated local mononuclear cells and may, have an important role in the pathogenesis of the disease.
Inflammatory cells, as well as several mediators, are suggested to have a role in the pathogenesis of ulcerative colitis and Crohn's disease. We have reported enhanced colonic synthesis of prostaglandin E2(PGE2), thromboxane A2 (TXA ) and prostacyclin (PGI2) in active ulcerative colitis'2 and lately also in Crohn's disease.3 Prostaglandins and thromboxanes (prostanoids) may be important not only as mediators of inflammation4 but also in the alteration of secretory and absorptive functions5 and in the impairment of cell mediated immunity. 6 Both colonic epithelial and mononuclear cells synthesise prostanoids. The enhanced colonic prostanoid synthesis can thus be because of either an increase in the number of intestinal mononuclear cells and/or an enhanced endogenous synthesis by one or both types of cells.
Intestinal mononuclear cells originate in the bone marrow and circulate in the blood.7 Peripheral blood mononuclear cells may also have an important role in the pathogenesis of inflammatory bowel disease: patients with inflammatory bowel disease have circulating T lymphocytes which have been sensitised to a multiplicity of colon and bacterial antigens.8 We have reported enhanced PGE2 and TXA2 synthesis by cultured perigheral blood mononuclear cells in Crohn's disease.
The aim of the present study was to utilise the mechanical and enzymatic methods to isolate intestinal epithelial and mononuclear cells in order to characterise the type of cell responsible for the enhanced intestinal prostanoid synthesis in inflammatory bowel disease and thus to better understand their possible role in the pathogenesis of the disease.
Methods

SUBJECTS
Colonic mucosa was obtained at surgery from five patients with ulcerative colitis who underwent total colectomy. Four of them were under steroid therapy at time of sugery. Inflamed ileal mucosa and normal ileal mucosa adjacent to areas of active disease were 659 obtained from four patients with Crohn's disease who underwent surgery, none of whom received steroids at least one month before the operation. None of the patients had ever received azathioprine or 6-mercaptopurine. For comparison, colonic tissue was obtained at surgery from 12 patients with adenocarcinoma of the colon from sites at least 10 cm from areas of disease and were both grossly and histologically normal.
ISOLATION OF INTESTINAL EPITHELIAL AND MONONUCLEAR CELLS
Intestinal epithelial and mononuclear cells were isolated according to Bull and Bookmanlo with some modidfications: Four 10 g pieces of intestinal mucosa were dissected from the underlying muscularis using iris scissors, cut into small fragments, washed in calcium and magnesium-free phosphate buffered saline (PBS, GIBCO, Grand Island, NY) and incubated with stirring for 10 minutes at room temperature in phosphate buffered saline containing 1 mM dithiothreitol (DDT) (Sigma PGE2, 6-keto-PGFl, the stable metabolite of PGI2, and TXB2, the stable metabolite of TXA2, were determined by a radioimmunoassay as previously described,9 12 and calculated per 1 mononuclear cells, which were over 95% viable by trypan-blue exclusion before and after 18 hours of culture. During 18 hours of culture both epithelial and mononuclear cells isolated from all groups of patients were found to secrete PGE2, PGI2 and TXA2 to the culture medium.
Cultured epithelial cells isolated from normal colonic mucosa obtained from patients with adenocarcinoma of the colon secreted to the medium similar amounts of all three prostanoids tested (Table 2) .
TXA2 accumulation by cultured epithelial cells isolated from intestinal mucosa of both Crohn's disease and ulcerative colitis patients was significantly higher than its accumulation by cells obtained from normal mucosa. Accumulation of PGE2 was significantly increased only by epithelial enriched cell suspensions isolated from Crohn's disease patients. There was no significant difference in PGI2 secretion among the three groups of patients.
Accumulation of the three prostanoids tested by cultured epithelial cell suspensions depleted of adherent and phagocytic cells was not significantly different from their respective accumulation by the crude cell suspensions (Table 2 ). Mononuclear cells isolated from normal mucosa secreted four times more PGE2 and twice more PGI2 and TXA2 than isolated epithelial cells (Tables 2 and 3) . Synthesis of the three prostanoids by cultured mononuclear cells was significantly higher than their respective synthesis by cultured epithelial cells in all groups of patients (Tables 2 and 3 Prostanoid synthesis by primary cultures of epithelial and mononuclear cells isolated from inflamed and uninflamed ileal mucosa of Crohn's disease patients, from colonic mucosa of ulcerative colitis patients was determined and compared with prostanoid synthesis by cells isolated from normal colonic mucosa of cancer patients. The finding that prostanoid synthesis by cultured mononuclear cells isolated from normal, uninflamed ileal mucosa of Crohn's disease patients is similar to that of cultured mononuclear cells isolated from normal colonic mucosa of cancer patients, indicates that prostanoids synthesis by mononuclear cells isolated from normal ileal and colonic mucosa is similar, and validates the use of cells isolated from the colon of cancer patients as a control.
Cultured epithelial enriched cell suspensions isolated from normal colonic mucosa were found to secrete PGE2, PGI2 and TXA2. PGE2 and TXA2 secretion by cultured epithelial cells isolated from patients with active Crohn's disease were found to be significantly higher than their secretion by cultured epithelial cells isolated from normal mucosa. TXA2 secretion by cultured epithelial cells isolated from patients with ulcerative colitis was also stimulated, whereas enhanced PGE2 secretion was observed only by the non-adherent non-phagocytic cells.
The synthesis of all three prostanoids tested, by cultured intestinal mononuclear cells, was significantly stimulated only by cells isolated from inflamed sites of patients with Crohn's disease. Intestinal mononuclear cells originate in the bone marrow and circulate in the blood. 7 We have recently reported enhanced PGE2 and TXA2 synthesis by cultured peripheral blood mononuclear cells also only in patients with active Crohn's disease but not in patients with active ulcerative colitis.9 This difference may be because of the presence of a prostanoid inhibitor or a different subset of mononuclear cells in ulcerative colitis as previously suggested,9 or more likely owing to the fact that four out of the five ulcerative colitis patients included in the present study were under heavy steroid treatment. Corticosteroids inhibit prostanoid synthesis by limiting the substrate availability.13 It is of interest to note that the highest concentration of prostanoid synthesis by cultured intestinal mononuclear cells was observed in the only patient with ulcerative colitis who did not receive steroids for one month before surgery.
Both the epithelial and the mononuclear cell fractions were not pure. Each fraction contains variable proportions of the other cell poplation. As, however, the mononuclear cell fraction isolated from patients with active Crohn's disease was found to secrete at least four times more prostanoids than the epithelial cell fraction it is highly suggestive that this cell fraction is responsible for most of the enhanced synthesis observed in this disease. It may very well be that prostanoid synthesis by the epithelial enriched cell suspensions is derived from the presence of mononuclear cells contaminating this fraction. Plastic adherence and phagocytic activity are among the most useful criteria to identify and isolate monocytes and macrophages.11 Well and others14 have previously reported that most of prostanoid secretion by cultured peripheral blood mononuclears is derived from the adherent phagocytic cell population. In the present study, however, in which prostanoid synthesis by cultured mononuclear cells isolated from intestinal mucosa was determined, depletion of adherent and phagocytic cells did not affect their synthesis. The different origin of the mononuclear cells in both studies -that is, peripheral blood and intestinal mucosa -may explain this observation. The mechanism responsible for this difference is not clear and has to be elaborated.
In the cell suspensions obtained from the chronically inflamed mucosa of inflammatory bowel disease patients and from normal subjects, polymorphonuclear cells were not identified. This is in agreement with the established observation that mononuclear cells predominate in chronic inflammatory conditions. The addition of lipopolysaccharide to the medium also did not stimulate prostanoid synthesis by intestinal mononucler cells. This observation further supports the contention that mononuclear cells responsible for most of the intestinal prostanoid production are different from adherent phagocytic cells.
In conclusion, the cumulative data suggest that mononuclear cells have an important role in prostanoid synthesis by normal colonic mucosa as well as by the inflamed intestinal mucosa in inflammatory bowel disease patients. Moreover 
